Digital therapeutics firm Kaia Health is partnering with Italian pharma firm Chiesi Group to commercialise its chronic obstructive pulmonary disease (COPD) rehabilitation app in Europe.
The Kaia COPD solution consists of a mobile app and an interface for motivational support that aims to deliver a personalised pulmonary rehabilitation experience through education, daily training sessions and...
Digital respiratory health management company Propeller Health is collaborating with Novartis to develop a custom add-on sensor for the Swiss pharmaceutical company’s Breezhaler inhaler, which is used for Novartis’s portfolio of COPD treatments. The partnership will be focused in Europe.
The add-on sensor will be developed to work with the capsule-based dry powder inhaler by passively recording...
Madison, Wisconsin-based Propeller Health, which offers a digitally-guided respiratory therapy platform, has teamed up with Medical International Research (MIR) to offer several of the Italian health technology company’s mobile and clinical spirometers alongside the Propeller system.
The addition of sprirometers will give Propeller a more complete vision of the people using their platform, which...
Madison, Wisconsin-based Propeller Health, maker of several smart inhaler sensors and companion apps, has received FDA 510(k) clearance for its latest offering – a sensor that works with GlaxoSmithKline’s Ellipta inhaler.
This marks the company’s eighth FDA clearance, and was born out of a partnership the company struck up with GSK last December. Given Propeller's growing familiarity with the...
